Communiqués

29/01/24 Completion of the combination between Novozymes and Chr. Hansen GL
26/01/24 All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen GL
20/12/23 Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted GL
19/12/23 Major shareholder announcement from Burlington Loan Management DAC GL
12/12/23 Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained GL
20/11/23 Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission. GL
02/11/23 Managers' Transaction GL
13/10/23 Christian Hansen : Q4 Conference call transcript 2022/23 PU
13/10/23 Managers' Transactions GL
12/10/23 Christian Hansen : Q4 Investor presentation 2022/23 PU
12/10/23 Chr. Hansen Holding A/S Interim Report Q4 2022/23 GL
10/10/23 Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen GL
27/09/23 Major shareholder announcements from Burlington Loan Management DAC and Davidson Kempner Capital Management LP GL
04/09/23 Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion GL
30/08/23 Christian Hansen : Q4 Aide memoire 2022/23 PU
07/07/23 Christian Hansen : Q3 Conference call transcript 2022/23 PU
06/07/23 Christian Hansen : Q3 Investor presentation 2022/23 PU
06/07/23 Chr. Hansen Holding A/S Interim Report Q3 2022/23 GL
23/06/23 Christian Hansen : Change of Management in Bacthera AG PU
12/06/23 Christian Hansen : Chr. Hansen secures EU approval for the final HMO in its 5 HMO Mix PU
28/04/23 Christian Hansen : Chr. Hansen inaugurates new Customer & Application Center for Meat & Prepared Foods PU
14/04/23 Christian Hansen : Q2 Conference call transcript 2022/23 PU
13/04/23 Christian Hansen : Q2 Investor presentation 2022/23 PU
13/04/23 Chr. Hansen Holding A/S Interim Report Q2 2022/23 GL
13/04/23 Chr. Hansen Holding A/S Interim Report Q2 2022/23 GL
Aucun résultat pour cette recherche
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT